| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. | Director | Common Stock | 5,266 | $15,494 | $2.94 | 29 Jun 2021 | Indirect |
| G1 Therapeutics, Inc. | Director | Common Stock | 4,389 | $12,914 | $2.94 | 29 Jun 2021 | Direct |
| G1 Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 0 | 29 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000156218021004586-rudnick-seth-2021-06-29 | G1 Therapeutics, Inc. | 29 Jun 2021 | 5 | -$219,760 | 4 | Director | 30 Jun 2021, 16:05 |
| /report/000156218021004395-rudnick-seth-2021-06-17 | G1 Therapeutics, Inc. | 17 Jun 2021 | 2 | $0 | 4 | Director | 21 Jun 2021, 16:06 |